H Imaeda

Summary

Affiliation: Shiga University of Medical Science
Country: Japan

Publications

  1. ncbi Medium-chain triglycerides modulate ileitis induced by trinitrobenzene sulfonic acid
    T Tsujikawa
    The Second Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan
    J Gastroenterol Hepatol 14:1166-72. 1999
  2. ncbi Alteration in expression of polyamine and glucose-related enzyme mRNA after small bowel resection in the rat residual ileum
    Tomoyuki Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science, Tsukinowa cho, Seta, Otsu, Shiga 520 2192, Japan
    Int J Mol Med 10:489-92. 2002
  3. ncbi Enteral and parenteral nutrition therapy for Crohn's disease
    Tomoyuki Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science, Seta Tukinowa, Otsu 520 2192, Japan
    Curr Pharm Des 9:323-32. 2003
  4. ncbi Mucosal permeability regulates receptor binding of luminal epidermal growth factor in the adult rat intestine
    Tomoyuki Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science, Tsukinowa cho, Seta, Otsu, Shiga 520 2192, Japan
    Int J Mol Med 11:349-52. 2003
  5. ncbi Supplement of a chitosan and ascorbic acid mixture for Crohn's disease: a pilot study
    Tomoyuki Tsujikawa
    Department of Internal Medicine, Division of Gastroenterology, Shiga University of Medical Science, and the Kirin Brewery Co, Ltd, Research Institute of Life Science, Shiga, Japan
    Nutrition 19:137-9. 2003
  6. ncbi Operative indications for patients with refractory or severe ulcerative colitis
    Tomoyuki Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science, Shiga, Japan
    Hepatogastroenterology 52:1470-3. 2005
  7. ncbi Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease
    Tomoyuki Tsujikawa
    Department of Internal Medicine, Shiga University of Medical Science, Otsu
    Intern Med 48:933-7. 2009
  8. ncbi Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences
    T Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science Hospital, Shiga, Japan
    Endoscopy 40:11-5. 2008
  9. ncbi Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study
    Tomoyuki Tsujikawa
    Department of Internal Medicine, Shiga University of Medical Science, Seta Tukinowa, Otsu, Japan
    Ther Apher Dial 13:14-8. 2009
  10. ncbi Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease
    T Aomatsu
    Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa, Otsu, Japan
    Aliment Pharmacol Ther 34:941-8. 2011

Collaborators

Detail Information

Publications12

  1. ncbi Medium-chain triglycerides modulate ileitis induced by trinitrobenzene sulfonic acid
    T Tsujikawa
    The Second Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan
    J Gastroenterol Hepatol 14:1166-72. 1999
    ..Dietary fat in Crohn's disease is still a controversial risk factor for IBD. We therefore also studied the effects of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT) on TNBS ileitis...
  2. ncbi Alteration in expression of polyamine and glucose-related enzyme mRNA after small bowel resection in the rat residual ileum
    Tomoyuki Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science, Tsukinowa cho, Seta, Otsu, Shiga 520 2192, Japan
    Int J Mol Med 10:489-92. 2002
    ..The expression of glucose transport and glycolysis enzyme mRNAs did not increase after a small bowel resection...
  3. ncbi Enteral and parenteral nutrition therapy for Crohn's disease
    Tomoyuki Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science, Seta Tukinowa, Otsu 520 2192, Japan
    Curr Pharm Des 9:323-32. 2003
    ....
  4. ncbi Mucosal permeability regulates receptor binding of luminal epidermal growth factor in the adult rat intestine
    Tomoyuki Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science, Tsukinowa cho, Seta, Otsu, Shiga 520 2192, Japan
    Int J Mol Med 11:349-52. 2003
    ..These results suggest that in the adult rat intestine, luminal EGF may play a role only under tissue damage, where enhanced permeability permits the EGF to pass through the mucosa and bind to its receptor on the basolateral membrane...
  5. ncbi Supplement of a chitosan and ascorbic acid mixture for Crohn's disease: a pilot study
    Tomoyuki Tsujikawa
    Department of Internal Medicine, Division of Gastroenterology, Shiga University of Medical Science, and the Kirin Brewery Co, Ltd, Research Institute of Life Science, Shiga, Japan
    Nutrition 19:137-9. 2003
    ..We designed a pilot trial to investigate the tolerability and amount of fat excretion after the oral administration of a chitosan and ascorbic mixture for inactive Crohn's disease...
  6. ncbi Operative indications for patients with refractory or severe ulcerative colitis
    Tomoyuki Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science, Shiga, Japan
    Hepatogastroenterology 52:1470-3. 2005
    ..Since new treatments using cyclosporin A and leukocytapheresis have been developed, we analyzed historical changes in the operative indications for UC...
  7. ncbi Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease
    Tomoyuki Tsujikawa
    Department of Internal Medicine, Shiga University of Medical Science, Otsu
    Intern Med 48:933-7. 2009
    ..We investigated whether steroid therapy for Crohn's disease (CD) patients influences bone mineral density (BMD), and whether alendronate is effective for improving this loss of BMD...
  8. ncbi Novel single-balloon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences
    T Tsujikawa
    Division of Gastroenterology, Shiga University of Medical Science Hospital, Shiga, Japan
    Endoscopy 40:11-5. 2008
    ..The aim of the present study was to evaluate the insertion technique, the safety, and the clinical impact of the SBE system...
  9. ncbi Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study
    Tomoyuki Tsujikawa
    Department of Internal Medicine, Shiga University of Medical Science, Seta Tukinowa, Otsu, Japan
    Ther Apher Dial 13:14-8. 2009
    ..This preliminary study showed that five consecutive LCAP sessions are safe and feasible for active UC patients. The therapeutic efficacy and suitable patients for this treatment protocol should be confirmed by further studies...
  10. ncbi Faecal chitinase 3-like-1: a novel biomarker of disease activity in paediatric inflammatory bowel disease
    T Aomatsu
    Department of Medicine, Shiga University of Medical Science, Seta Tsukinowa, Otsu, Japan
    Aliment Pharmacol Ther 34:941-8. 2011
    ..Chitinase 3-like-1 (CHI3L1) is up-regulated in the inflamed mucosa of inflammatory bowel disease (IBD)...
  11. ncbi The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease
    T Sugihara
    Department of Medicine, Shiga University of Medical Science, Otsu, Japan
    Clin Exp Immunol 160:386-93. 2010
    ..C3 and IL-17 mRNA expressions are enhanced, with a strong correlation, in the inflamed mucosa of IBD patients. Part of these clinical findings was considered to be mediated by the colonic SEMF response to IL-17...
  12. ncbi A new technique for endoscopic submucosal dissection for early gastric cancer using an external grasping forceps
    H Imaeda
    Center for Diagnostic and Therapeutic Endoscopy, Keio University Hospital, Tokyo, Japan
    Endoscopy 38:1007-10. 2006
    ..Endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) has improved the success rate of en-bloc resection. We report here on a new technique using an external grasping forceps...